182 related articles for article (PubMed ID: 33925109)
21. [Diagnostic accuracy of 18F-FDG positron emission tomography for evaluation of hepatocellular carcinoma].
Shin JA; Park JW; An M; Choi JI; Kim SH; Kim SK; Lee WJ; Park SJ; Hong EK; Kim CM
Korean J Hepatol; 2006 Dec; 12(4):546-52. PubMed ID: 17237633
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of 11C-acetate and 18F-FDG PET/CT in mouse multidrug resistance gene-2 deficient mouse model of hepatocellular carcinoma.
Territo PR; Maluccio M; Riley AA; McCarthy BP; Fletcher J; Tann M; Saxena R; Skill NJ
BMC Med Imaging; 2015 May; 15():15. PubMed ID: 25981587
[TBL] [Abstract][Full Text] [Related]
23. Different glucose uptake and glycolytic mechanisms between hepatocellular carcinoma and intrahepatic mass-forming cholangiocarcinoma with increased (18)F-FDG uptake.
Lee JD; Yang WI; Park YN; Kim KS; Choi JS; Yun M; Ko D; Kim TS; Cho AE; Kim HM; Han KH; Im SS; Ahn YH; Choi CW; Park JH
J Nucl Med; 2005 Oct; 46(10):1753-9. PubMed ID: 16204727
[TBL] [Abstract][Full Text] [Related]
24. Detection of hepatocellular carcinoma with PET/CT: a prospective comparison of 18F-fluorocholine and 18F-FDG in patients with cirrhosis or chronic liver disease.
Talbot JN; Fartoux L; Balogova S; Nataf V; Kerrou K; Gutman F; Huchet V; Ancel D; Grange JD; Rosmorduc O
J Nucl Med; 2010 Nov; 51(11):1699-706. PubMed ID: 20956466
[TBL] [Abstract][Full Text] [Related]
25. Early dynamic 18F-FDG PET to detect hyperperfusion in hepatocellular carcinoma liver lesions.
Schierz JH; Opfermann T; Steenbeck J; Lopatta E; Settmacher U; Stallmach A; Marlowe RJ; Freesmeyer M
J Nucl Med; 2013 Jun; 54(6):848-54. PubMed ID: 23528383
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of
Ida Y; Tamai H; Shingaki N; Shimizu R; Maeshima S; Maekita T; Iguchi M; Terada M; Kitano M
Cancer Imaging; 2020 Oct; 20(1):74. PubMed ID: 33076990
[TBL] [Abstract][Full Text] [Related]
27. Potential and Clinical Significance of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Evaluating Liver Cancer Response to Lenvatinib Treatment.
Yamashige D; Kawamura Y; Kobayashi M; Shindoh J; Kobayashi Y; Okubo S; Muraishi N; Kajiwara A; Iritani S; Fujiyama S; Hosaka T; Saitoh S; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Ikeda K; Arase Y; Hashimoto M; Kumada H
Oncology; 2021; 99(3):169-176. PubMed ID: 33207358
[TBL] [Abstract][Full Text] [Related]
28. Detection of hepatocellular carcinoma using 11C-choline PET: comparison with 18F-FDG PET.
Yamamoto Y; Nishiyama Y; Kameyama R; Okano K; Kashiwagi H; Deguchi A; Kaji M; Ohkawa M
J Nucl Med; 2008 Aug; 49(8):1245-8. PubMed ID: 18632827
[TBL] [Abstract][Full Text] [Related]
29. Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma.
Hirata H; Sugimachi K; Komatsu H; Ueda M; Masuda T; Uchi R; Sakimura S; Nambara S; Saito T; Shinden Y; Iguchi T; Eguchi H; Ito S; Terashima K; Sakamoto K; Hirakawa M; Honda H; Mimori K
Cancer Res; 2016 Jun; 76(11):3265-76. PubMed ID: 27197151
[TBL] [Abstract][Full Text] [Related]
30. Combined hyperpolarized
Hansen AE; Gutte H; Holst P; Johannesen HH; Rahbek S; Clemmensen AE; Larsen MME; Schøier C; Ardenkjaer-Larsen J; Klausen TL; Kristensen AT; Kjaer A
Eur J Radiol; 2018 Jun; 103():6-12. PubMed ID: 29803387
[TBL] [Abstract][Full Text] [Related]
31. 18F-FDG-PET and histopathology in 131I-lipiodol treatment for primary liver cancer.
Risse JH; Pauleit D; Bender H; Rabe C; Fischer HP; Biersack HJ; Bucerius J
Cancer Biother Radiopharm; 2009 Aug; 24(4):445-52. PubMed ID: 19694579
[TBL] [Abstract][Full Text] [Related]
32. Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in predicting treatment response in unresectable hepatocellular carcinoma patients treated with external beam radiotherapy.
Kim JW; Seong J; Yun M; Lee IJ; Yoon HI; Cho HJ; Han KH
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1172-8. PubMed ID: 21570203
[TBL] [Abstract][Full Text] [Related]
33. Analysis of gene expression profiles of hepatocellular carcinomas with regard to 18F-fluorodeoxyglucose uptake pattern on positron emission tomography.
Lee JD; Yun M; Lee JM; Choi Y; Choi YH; Kim JS; Kim SJ; Kim KS; Yang WI; Park YN; Han KH; Lee WJ; Yoo N; Lim SM; Park JH
Eur J Nucl Med Mol Imaging; 2004 Dec; 31(12):1621-30. PubMed ID: 15278306
[TBL] [Abstract][Full Text] [Related]
34. Glucose metabolism gene expression patterns and tumor uptake of ¹⁸F-fluorodeoxyglucose after radiation treatment.
Wilson GD; Thibodeau BJ; Fortier LE; Pruetz BL; Galoforo S; Baschnagel AM; Chunta J; Oliver Wong CY; Yan D; Marples B; Huang J
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):620-7. PubMed ID: 25304950
[TBL] [Abstract][Full Text] [Related]
35. Integrin α6 targeted positron emission tomography imaging of hepatocellular carcinoma in mouse models.
Feng GK; Ye JC; Zhang WG; Mei Y; Zhou C; Xiao YT; Li XL; Fan W; Wang F; Zeng MS
J Control Release; 2019 Sep; 310():11-21. PubMed ID: 31400382
[TBL] [Abstract][Full Text] [Related]
36. Clinical implication of glucose transport and metabolism evaluated by 18F-FDG PET in hepatocellular carcinoma.
Paudyal B; Paudyal P; Oriuchi N; Tsushima Y; Nakajima T; Endo K
Int J Oncol; 2008 Nov; 33(5):1047-54. PubMed ID: 18949368
[TBL] [Abstract][Full Text] [Related]
37. [Cancer metabolism: a novel perspective on precision diagnosis and treatment for liver cancer].
Ning Z; Tan G
Zhonghua Wai Ke Za Zhi; 2020 Jan; 58(1):31-36. PubMed ID: 31902167
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis of Hepatocellular Carcinoma Using C11 Choline PET/CT: Comparison with F18 FDG, ContrastEnhanced MRI and MDCT.
Chotipanich C; Kunawudhi A; Promteangtrong C; Tungsuppawattanakit P; Sricharunrat T; Wongsa P
Asian Pac J Cancer Prev; 2016; 17(7):3569-73. PubMed ID: 27510010
[TBL] [Abstract][Full Text] [Related]
39. Molecular mechanisms of [18F]fluorodeoxyglucose accumulation in liver cancer.
Izuishi K; Yamamoto Y; Mori H; Kameyama R; Fujihara S; Masaki T; Suzuki Y
Oncol Rep; 2014 Feb; 31(2):701-6. PubMed ID: 24297035
[TBL] [Abstract][Full Text] [Related]
40. Clinical value of pre-and postoperative 18F-FDG PET/CT in patients undergoing liver transplantation for hepatocellular carcinoma.
Wang XL; Li H; Wang QS; Zhang XL
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1087-91, 1095. PubMed ID: 16939890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
